Rediff Logo
Money
Line
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Wedding | Women
Partner Channels: Bill Pay | Health | IT Education | Jobs | Technology | Travel
Line
Home > Money > Business Headlines > Report
July 16, 2001
Feedback  
  Money Matters

 -  Business Special
 -  Business Headlines
 -  Corporate Headlines
 -  Columns
 -  IPO Center
 -  Message Boards
 -  Mutual Funds
 -  Personal Finance
 -  Stocks
 -  Tutorials
 -  Search rediff

    
      



 
 Search the Internet
         Tips
 Sites: Finance, Investment
E-Mail this report to a friend
Print this page

Cialis: Canada's answer to Viagra

Ajit Jain
India Abroad Correspondent in Toronto

The Canadians have come up with an answer to Viagra, the anti-impotence drug. The new pill, now under clinical trial in Canada, is likely to hit the markets soon and is claimed to be better than Pfizer's Viagra.

Cialis, the new pill being developed by Lily Icos, will be submitted within a couple of weeks to the Canadian Department of Health for scrutiny and approval, says Dr Gerald Brock, a Urologist in London, Ontario, and lead researcher for the study.

Cialis has demonstrated improved erections in 88 per cent of the 4,000 men studied worldwide, he said.

Based on reactions of his patients, who are part of the clinical trial, effect of Cialis lasts longer and has few side effects compared to Viagra, Brock reportedly stated.

"Men have reported it lasting up to 36 hours, which means if he takes it Friday night it will still be effective Saturday night, enabling multiple successful intercourse attempts," Brock was quoted as saying.

"It's also fast acting with men achieving an erection after sexual stimulation within 16 minutes of taking the 20 mg pill. That's fairly significant."

Its side effects are negligible: include headache, mild backache, some facial flushing and stomach upset and these, according to the Canadian urologist, are "probably because this drug is more specific and those side effects improve over time."

"About 90 per cent of the men in the clinical trials stayed with the drug even though there are many hurdles to get over when taking part in the research," added Brock.

He went on to claim that "...Canada is certainly front and center in leading the research on Cialis."

Cialis was submitted to the US Food and Drug Administration two weeks back for approval and it will also be submitted to Europe next week for approval.

Brock is excited. He believes that "men do not need to pretend their problem does not exist. It can be treated and this new drug holds great promise."

Money

Business News

Tell us what you think of this report